These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17047888)

  • 1. A case of polymyositis complicated with myasthenic crisis.
    Yoshidome Y; Morimoto S; Tamura N; Kobayashi S; Tsuda H; Hashimoto H; Takasaki Y
    Clin Rheumatol; 2007 Sep; 26(9):1569-70. PubMed ID: 17047888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myasthenic Crisis Complicated with Myxedema, Positive for Both Anti-acetylcholine Receptor and Anti-muscle-specific Tyrosine Kinase Antibodies.
    Horiuchi K; Nagai A; Wakita M; Ito S; Takamura K; Houzen H
    Intern Med; 2018 Jan; 57(2):265-268. PubMed ID: 29093409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictable recovery from myasthenia gravis crisis with plasma exchange: thirty-six cases and review of current management.
    Mahalati K; Dawson RB; Collins JO; Mayer RF
    J Clin Apher; 1999; 14(1):1-8. PubMed ID: 10355656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercapnic respiratory failure during pregnancy due to polymyositis-related respiratory muscle weakness: a case report.
    Ali HS; Hassan IF; George S; Fadlelmula AE
    J Med Case Rep; 2017 Jul; 11(1):203. PubMed ID: 28743311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange].
    Suzuki H; Motomura M; Yoshimura T; Shiraishi H; Mitsui Y; Hasegawa T; Atsumi M; Kitaguchi M; Kusunoki S
    Rinsho Shinkeigaku; 2005 Jul; 45(7):510-3. PubMed ID: 16119834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of scleromyositis associated with PM-Scl antibody and myasthenia.
    Hausmanowa-Petrusewicz I; Blaszczyk M; Jablońska S
    Neuromuscul Disord; 1995 Mar; 5(2):145-7. PubMed ID: 7767094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory insufficiency from myasthenia gravis and polymyositis due to malignant thymoma triggering Takotsubo syndrome.
    Finsterer J; Stöllberger C; Ho CY
    Int J Neurosci; 2018 Dec; 128(12):1207-1210. PubMed ID: 29883223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.
    Yamada C; Teener JW; Davenport RD; Cooling L
    J Clin Apher; 2015 Oct; 30(5):314-9. PubMed ID: 25557356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative myasthenic crisis successfully treated with immunoadsorption therapy.
    Ishizeki J; Nishikawa K; Kunimoto F; Goto F
    J Anesth; 2005; 19(4):320-2. PubMed ID: 16261471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis: management of myasthenic crisis and perioperative care.
    Juel VC
    Semin Neurol; 2004 Mar; 24(1):75-81. PubMed ID: 15229794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exchange therapy for severe penicillamine-induced myasthenia gravis.
    Lang AE; Humphrey JG; Gordn DA
    J Rheumatol; 1981; 8(2):303-7. PubMed ID: 7230162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
    Szpirt W; Somnier F; Nielsen FC; Rødgaard A
    Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy for anti-MuSK antibody positive myasthenia gravis].
    Pál Z; Boczán J; Bereznai B; Lovas G; Molnár MJ
    Orv Hetil; 2011 Sep; 152(39):1586-9. PubMed ID: 21920845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy].
    Matsumoto R; Motomura M; Yoshimura T; Kohara N; Kato T
    Rinsho Shinkeigaku; 1999 May; 39(5):531-7. PubMed ID: 10424144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myasthenia gravis].
    Sato H; Araki S
    Nihon Rinsho; 1990 Jul; 48(7):1470-6. PubMed ID: 2402064
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis.
    Wang R; Li J; Wang M; Hao H; Chen X; Li R; Zhu X
    Br J Dermatol; 2015 Apr; 172(4):968-75. PubMed ID: 25388377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological studies on myasthenia gravis and thymus].
    Kawaguchi T; Tani A; Koie H
    Kokyu To Junkan; 1988 Oct; 36(10):1101-4. PubMed ID: 3247525
    [No Abstract]   [Full Text] [Related]  

  • 20. Muscle-specific tyrosine kinase-antibody-positive myasthenic crisis with detailed electrophysiologic studies.
    Yanagawa Y; Hongo Y; Shiozaki H; Kamakura K; Sonoo M; Motomura M
    Am J Emerg Med; 2009 Jul; 27(6):754.e5-6. PubMed ID: 19751644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.